Maintaining the recent expansion of palliative care access in the United States is a recognized public health concern. Economic evaluation is essential to validate current provision and assess the case for new programs. Previous economic reviews in palliative care reported on programs across settings and systems; none has examined specifically the hospital consultative model, the dominant model of provision in the United States.
Objectives:
To review systematically the economic evidence on specialist palliative care consultation teams in the hospital setting, to appraise this evidence critically, and to identify areas for future research in this field.
Data Sources:
A meta-review (“a review of existing reviews”) was conducted of eight published systematic reviews and one relevant nonsystematic review. To identify articles published outside of the timeframe of these reviews, systematic searches were performed on the PubMed, CINAHL, and EconLit databases.
Study Selection:
Articles were included if they compared the costs and/or cost effectiveness of a specialist hospital inpatient palliative care consultation for adult patients with those of a comparator.
Results:
Ten studies were included and these demonstrate a clear pattern of cost-saving impact from inpatient consultation programs. Nevertheless, knowledge gaps still exist regarding the economic effects of these programs. Current evidence has been generated from the hospital perspective; health system costs, patient and caregiver costs, and health outcomes are typically not included.
Conclusions:
Inpatient palliative care consultation programs have been shown to save hospitals money and to provide improved care to patients with serious illness. With a clear pattern of cost-saving using current methodology, it is timely to begin expanding the scope of economic evaluation in this field. Future research must address the measurement of both costs and outcomes to understand more fully the role that palliative care plays in enhancing value in health care. Relevant domains for such research are identified.
DaviesE, HigginsonI: The Solid Facts: Palliative Care. Copenhagen: World Health Organization, Regional Office for Europe, 2004.
3.
DaviesE, HigginsonI: Better Palliative Care for Older People. Copenhagen: World Health Organization, Regional Office for Europe, 2004.
4.
GoldsmithB, DietrichJ, DuQ, MorrisonRS: Variability in access to hospital palliative care in the United States. J Palliat Med, 2008; 11:1094–1102.
5.
MeierDE: Increased access to palliative care and hospice services: Opportunities to improve value in health care. Milbank Q, 2011; 89:343–380.
6.
GoldsteinNE, MorrisonRS: The intersection between geriatrics and palliative care: A call for a new research agenda. J Am Geriatr Soc, 2005; 53:1593–1598.
7.
GelfmanLP, DuQ, MorrisonRS: An update: NIH research funding for palliative medicine 2006 to 2010. J Palliat Med, 2013; 16:125–129.
8.
HigginsonIJ, EvansCJ, GrandeG, PrestonN, MorganM, McCroneP, LewisP, FayersP, HardingR, HotopfM, MurraySA, BenaliaH, GyselsM, FarquharM, ToddC; MORECare: Evaluating complex interventions in end of life care: The MORECare statement on good practice generated by a synthesis of transparent expert consultations and systematic reviews. BMC Med, 2013; 11:111.
9.
MeierDE, BeresfordL: Palliative care cost research can help other palliative care programs make their case. J Palliat Med, 2009; 12:15–20.
10.
SmithTJ, HillnerBE: Bending the cost curve in cancer care. N Engl J Med, 2011; 364:2060–2065.
11.
GomesB, HardingR, FoleyKM, HigginsonIJ: Optimal approaches to the health economics of palliative care: Report of an international think tank. J Pain Symptom Manage, 2009; 38:4–10.
12.
HigginsonIJ, FinlayI, GoodwinDM, CookAM, HoodK, EdwardsAG, DouglasHR, NormanCE: Do hospital-based palliative teams improve care for patients or families at the end of life?. J Pain Symptom Manage, 2002; 23:96–106.
13.
DouglasHR, HallidayD, NormandC, CornerJ, BathP, BeechN, ClarkD, HughesP, MarplesR, SeymourJ, SkilbeckJ, WebbT: Economic evaluation of specialist cancer and palliative nursing: A literature review. Int J Palliat Nurs, 2003; 9:424–428.
14.
HigginsonIJ, FinlayIG, GoodwinDM, HoodK, EdwardsAG, CookA, DouglasHR, NormandCE: Is there evidence that palliative care teams alter end-of-life experiences of patients and their caregivers?. J Pain Symptom Manage, 2003; 25:150–168.
15.
ZimmermannC, RiechelmannR, KrzyzanowskaM, RodinG, TannockI: Effectiveness of specialized palliative care: A systematic review. JAMA, 2008; 299:1698–1709.
16.
HigginsonIJ, EvansCJ: What is the evidence that palliative care teams improve outcomes for cancer patients and their families?. Cancer J, 2010; 16:423–435.
El-JawahriA, GreerJA, TemelJS: Does palliative care improve outcomes for patients with incurable illness? A review of the evidence. J Support Oncol, 2011; 9:87–94.
19.
SmithS, BrickA, O'HaraS, NormandC: Evidence on the cost and cost-effectiveness of palliative care: A literature review. Palliat Med, 2014; 28:130–150.
20.
Centre for Reviews and Dissemination, University of York: Systematic Reviews: CRD's Guidance for Undertaking Reviews in Health Care. York: CRD, University of York, 2009.
21.
SmithTJ, CasselJB: Cost and non-clinical outcomes of palliative care. J Pain Symptom Manage, 2009; 38:32–44.
22.
DrummondMF, JeffersonTO: Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ, 1996; 313:275–283.
23.
CowanJD: Hospital charges for a community inpatient palliative care program. Am J Hosp Palliat Care, 2004; 21:177–190.
24.
PenrodJD, DebP, LuhrsC, DellenbaughC, ZhuCW, HochmanT, MaciejewskiML, GranieriE, MorrisonRS: Cost and utilization outcomes of patients receiving hospital-based palliative care consultation. J Palliat Med, 2006; 9:855–860.
25.
CieminsEL, BlumL, NunleyM, LasherA, NewmanJM: The economic and clinical impact of an inpatient palliative care consultation service: A multifaceted approach. J Palliat Med, 2007; 10:1347–1355.
26.
BendalyEA, GrovesJ, JuliarB, GramelspacherGP: Financial impact of palliative care consultation in a public hospital. J Palliat Med, 2008; 11:1304–1308.
27.
GadeG, VenohrI, ConnerD, McGradyK, BeaneJ, RichardsonRH, WilliamsMP, LibersonM, BlumM, Della PennaR: Impact of an inpatient palliative care team: A randomized control trial. J Palliat Med, 2008; 11:180–190.
28.
HansonLC, UsherB, SpragensL, BernardS: Clinical and economic impact of palliative care consultation. J Pain Symptom Manage, 2008; 35:340–346.
29.
MorrisonRS, PenrodJD, CasselJB, Caust-EllenbogenM, LitkeA, SpragensL, MeierDE; Palliative Care Leadership Centers' Outcomes Group: Cost savings associated with US hospital palliative care consultation programs. Arch Intern Med, 2008; 168:1783–1790.
WhitfordK, ShahND, MoriartyJ, BrandaM, ThorsteinsdottirB: Impact of a palliative care consult service. Am J Hosp Palliat Care, 2014; 31:175–182.
34.
DrummondMF, SculpherMJ, TorranceGW, O'BrienBJ, StoddartGL: Methods for the Economic Evaluation of Health Care Programmes, 3rd ed. Oxford: Oxford University Press, 2005.
35.
GoldMR: Cost-Effectiveness in Health and Medicine. New York/Oxford: Oxford University Press, 1996.
36.
Tibi-LevyY, Le VaillantM, de PouvourvilleG: Determinants of resource utilization in four palliative care units. Palliat Med, 2006; 20:95–106.
37.
Gomez-BatisteX, TucaA, CorralesE, Porta-SalesJ, AmorM, EspinosaJ, BorràsJM, de la MataI, Castellsagué X; Grupo de Evaluación-SECPAL: Resource consumption and costs of palliative care services in Spain: A multicenter prospective study. J Pain Symptom Manage, 2006; 31:522–532.
38.
KelleyAS, EttnerSL, MorrisonRS, DuQ, WengerNS, SarkisianCA: Determinants of medical expenditures in the last 6 months of life. Ann Intern Med, 2011; 154:235–242.
39.
GroeneveldI, MurtaghF, KalokiY, BauseweinC, HigginsonI: Determinants of Healthcare Costs in the Last Year of Life. The Annual Assembly of American Academy of Hospice and Palliative Medicine & Hospice and Palliative Nurses Association;. New Orleans, LA: March14, 2013.
40.
PrestonNJ, ShortV, HollingworthW, McCroneP, GrandeG, EvansC, et al.MORECare research methods guidance development: Recommendations for health economic evaluation in palliative and end of life care research [abstract]. Palliat Med, 2012; 26:541.
41.
NormandC: Measuring outcomes in palliative care: Limitations of QALYs and the road to PalYs. J Pain Symptom Manage, 2009; 38:27–31.
42.
RoundJ: Is a QALY still a QALY at the end of life?. J Health Econ, 2012; 31:521–527.
43.
NormandC: Setting priorities in and for end-of-life care: Challenges in the application of economic evaluation. Health Econ Policy Law, 2012; 7:431–439.
44.
HigginsonIJ, McCroneP, HartSR, BurmanR, SilberE, EdmondsPM: Is short-term palliative care cost-effective in multiple sclerosis? A randomized phase II trial. J Pain Symptom Manage, 2009; 38:816–826.
